Greenleaf Trust increased its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 15.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 5,201 shares of the company’s stock after acquiring an additional 694 shares during the period. Greenleaf Trust’s holdings in Cardinal Health were worth $615,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Paragon Capital Management Inc. increased its position in shares of Cardinal Health by 0.7% in the third quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company’s stock worth $1,642,000 after purchasing an additional 99 shares during the last quarter. Huntington National Bank grew its stake in Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after buying an additional 100 shares in the last quarter. Frazier Financial Advisors LLC increased its holdings in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares during the last quarter. UMB Bank n.a. raised its position in shares of Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after buying an additional 106 shares in the last quarter. Finally, Raleigh Capital Management Inc. lifted its holdings in shares of Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock worth $55,000 after acquiring an additional 106 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research firms recently commented on CAH. Barclays increased their target price on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday, January 7th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. JPMorgan Chase & Co. lifted their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Wells Fargo & Company upped their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $135.93.
Cardinal Health Stock Performance
NYSE CAH opened at $125.29 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The stock has a market cap of $30.27 billion, a P/E ratio of 23.38, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63. The stock has a 50 day simple moving average of $122.16 and a two-hundred day simple moving average of $114.75.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts predict that Cardinal Health, Inc. will post 7.92 earnings per share for the current year.
Cardinal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.61%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- The 3 Best Retail Stocks to Shop for in August
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Calculate Stock Profit
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.